Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

Open access
Casanova, Ramon, Varma, Sudhir, Simpson, Brittany, Kim, Min, An, Yang, Saldana, Santiago, Riveros, Carlos, Moscato, Pablo, Griswold, Michael, Sonntag, Denise, Wahrheit, Judith, Klavins, Kristaps, Jonsson, Palmi V., Eiriksdottir, Gudny, Aspelund, Thor, Launer, Lenore J., Gudnason, Vilmundur, Legido Quigley, Cristina, Thambisetty, Madhav · 2016 · Alzheimer's & Dementia

Abstract

Introduction: Recently, quantitative metabolomics identified a panel of 10 plasma lipids that were highly predictive of conversion to Alzheimer's disease (AD) in cognitively normal older individuals (n = 28, area under the curve [AUC] = 0.92, sensitivity/specificity of 90%/90%). Methods: Quantitative targeted metabolomics in serum using an identical method as in the index study. Results: We failed to replicate these findings in a substantially larger study from two independent cohorts—the Baltimore Longitudinal Study of Aging ([BLSA], n = 93, AUC = 0.642, sensitivity/specificity of 51.6%/65.7%) and the Age, Gene/Environment Susceptibility‐Reykjavik Study ([AGES‐RS], n = 100, AUC = 0.395, sensitivity/specificity of 47.0%/36.0%). In analyses applying machine learning methods to all 187 metabolite concentrations assayed, we find a modest signal in the BLSA with distinct metabolites associated with the preclinical and symptomatic stages of AD, whereas the same methods gave poor classification accuracies in the AGES‐RS samples. Discussion: We believe that ours is the largest blood biomarker study of preclinical AD to date. These findings underscore the importance of large‐scale independent validation of index findings from biomarker studies with relatively small sample sizes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2015.12.008

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 162

Metadata

Authors
Casanova, R., Varma, S., Simpson, B., Kim, M., An, Y., Saldana, S., Riveros, C., Moscato, P., Griswold, M., Sonntag, D., Wahrheit, J., Klavins, K., Jonsson, P. V., Eiriksdottir, G., Aspelund, T., Launer, L. J., Gudnason, V., Legido Quigley, C., & Thambisetty, M.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2016-01-21
Volume
12
Issue
7
Pages
815-822
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2274063159
Cited by
162
References
10
FWCI
17.33
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. https://app.cochat.ai/papers/10.1016/j.jalz.2015.12.008
The paper
Casanova, R., Varma, S., Simpson, B., Kim, M., An, Y., Saldana, S., Riveros, C., Moscato, P., Griswold, M., Sonntag, D., Wahrheit, J., Klavins, K., Jonsson, P. V., Eiriksdottir, G., Aspelund, T., Launer, L. J., Gudnason, V., Legido Quigley, C., & Thambisetty, M. (2016). Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.12.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.